PAALX
Price
$12.13
Change
+$0.01 (+0.08%)
Updated
Jun 22 closing price
Net Assets
10.46B
PWDCX
Price
$11.66
Change
+$0.07 (+0.60%)
Updated
Jun 22 closing price
Net Assets
76.83M
Interact to see
Advertisement

PAALX vs PWDCX

PAALX vs PWDCX Comparison Chart in %
View a ticker or compare two or three
VS
PAALX vs. PWDCX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAALX is a Hold and PWDCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PAALX has more cash in the bank: 10.5B vs. PWDCX (76.8M). PAALX pays higher dividends than PWDCX: PAALX (6.91) vs PWDCX (0.93). PAALX was incepted earlier than PWDCX: PAALX (23 years) vs PWDCX (12 years). PWDCX (2.63) is less costly to investors than PAALX (2.17). PWDCX is a more actively managed with annual turnover of: 181.00 vs. PAALX (40.00). PWDCX has a lower initial minimum investment than PAALX: PWDCX (1000) vs PAALX (1000000). PWDCX annual gain was more profitable for investors over the last year : 22.23 vs. PAALX (16.86). PWDCX return over 5 years is better than : 34.97 vs. PAALX (25.06).
PAALXPWDCXPAALX / PWDCX
Total Expense Ratio2.082.6379%
Annual Report Gross Expense Ratio2.172.6382%
Fund Existence23 years12 years-
Gain YTD8.4749.78087%
Front LoadN/AN/A-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets10.5B76.8M13,672%
Annual Yield % from dividends6.910.93741%
Returns for 1 year16.8622.2376%
Returns for 3 years34.1648.7370%
Returns for 5 years25.0634.9772%
Returns for 10 years94.3722.31423%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICSCX35.94N/A
N/A
William Blair Small Cap Value I
VHCIX140.27N/A
N/A
Vanguard Health Care Index Admiral
INGIX23.18N/A
N/A
Voya US Stock Index Port I
MGOCX31.48-0.06
-0.19%
NYLI WMC Enduring Capital Class C
BMPEX26.43-0.29
-1.09%
Beck Mack + Oliver Partners